Hints and tips:
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Brent crude, the international standard, was up 8.5 per cent at $42.83 in recent trading....
...Thompson said Beijing’s consistent economic coercion of not just Taiwan was a “global challenge . . . and it really needs a global solution”....
...“This is not going to be a V-shaped recovery from here given the many months [or] years it will take for full repair, but it feels good now.”...
...Oil prices are retreating, although Brent crude is holding above $40 a barrel after this weekend’s meeting of big producers....
...A planned takeover of Allergan by US drugmaker Pfizer in 2015 fell through a year later when Barack Obama’s administration took steps to scupper a deal which was designed to help Pfizer escape paying US...
...Kirsten Thompson Partner, Dentons As a technology and then privacy lawyer, Kirsten Thompson recognised the importance of data early on....
...Lentz joins from Thompson & Knight. Latham & Watkins has hired Meghan Cocci as a partner in the law firm’s corporate department....
...As part of the deal, two directors at Allergan including its chairman and chief executive, Brent Saunders, will join AbbVie’s board....
...Two months ago, AbbVie chief executive Rick Gonzalez approached his counterpart at Allergan, Brent Saunders, with a proposition he believed could solve a series of problems facing their respective drug companies...
...Brent first month’s $34.50 a barrel, up more than 6 per cent on the day, with WTI up an exciting 8.8 per cent at $32 a barrel ahead of the June contract on Nymex expiring tomorrow....
...US drugmaker Pfizer has won its appeal against an £84.2m fine imposed by the UK’s competition regulator for sharply increasing the price of an epilepsy drug....
...‘Everybody’s been looking for the sign’ “It has been quite a week,” said Lise Buyer, who advises companies on their initial public offerings at Class V Group....
...We have Pfizer, we have Chiesi, we have [AstraZeneca] . . .[ and] Bohringer Ingelheim in this COPD space with huge amounts to offer and huge skin in the game.”...
...Thompson, a Briton who also chairs UK private equity group 3i, will take up the position in March, when Jan du Plessis steps down....
...Now its market capitalisation languishes at $52bn — less than half what Pfizer was willing to pay....
...-26.18 (-0.36%) at 7,300 CAC 40 unchanged 0.00 (0.00%) at 5,317 Dax unchanged 0.00 (0.00%) at 12,861 Currencies €/$ 1.18 (1.19) $/¥ 113.01 (112.10) £/$ 1.34 (1.35) €/£ 0.8818 (0.8818) Commodities ($) Brent...
...star Regulatory oversight has not kept up with growth in premiums Indian banks: power to the consumer Private-sector lenders exposed to the consumer sector should outperform European takeovers: Macron v...
...Pfizer, for example, raised the price of 148 drugs, including Viagra, its erectile dysfunction treatment, and Lyrica, for nerve pain....
...Pfizer, the largest standalone drugmaker in the US, has been listed as a petitioner in the IPR process on 25 occasions....
...Before the bell, Pfizer is set to report better-than-expected fourth-quarter results and investors will look for updates on the drugmaker’s plan to sell its multi-billion dollar consumer healthcare business...
International Edition